Bolt Biotherapeutics, Inc. (BOLT) Operating margin 2020–2025
Bolt Biotherapeutics, Inc. (BOLT) operating margin by fiscal year — reported operating income divided by reported revenue.
-469.3%FY2025 · since FY2020: -21290.9% → -469.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -469.3% | +480.6 pp |
| FY2024 | -949.9% | +17.5 pp |
| FY2023 | -967.4% | +609.1 pp |
| FY2022 | -1576.6% | +5787.6 pp |
| FY2021 | -7364.1% | +13926.8 pp |
| FY2020 | -21290.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice